
Welwaze Medical mission is to decrease breast cancer deaths. Celbrea, our disposable medical device for the early detection of breast disease, including breast cancer, has already been cleared by the FDA, European Union and by the health authorities in several other countries around the world.

Welwaze Medical mission is to decrease breast cancer deaths. Celbrea, our disposable medical device for the early detection of breast disease, including breast cancer, has already been cleared by the FDA, European Union and by the health authorities in several other countries around the world.
Headquarters: Miami, Florida
Core product: Celbrea Thermal Mapping Device (FDA-cleared)
Mission: Early detection of breast disease to decrease breast cancer deaths
Employees: 22
Total funding: $27.5M
Early detection and monitoring of breast disease/breast health
MedTech / Women's Health
Latest funding round listed on external profiles
“StartUp Health listed as an investor”